Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT01114958
Eligibility Criteria:
Inclusion Criteria:
* Primary lung cancer (any type) or dominant lung metastases from other primary cancers.
* Patients must have either measurable or evaluable disease.
* Karnofsky performance status ≥ 70%.
* Greater than 18 years of age.
* Life expectancy \> 3 months.
* 3 week elapse from previous cytotoxic therapy (except for erlotinib or hormonal therapy, which can be ongoing) with side effects improved to grade 2 or less, and no prior radiotherapy to the lung.
* Adequate organ function.
* Treated brain metastases, if present, with toxicities improved to grade 2 or less.
* Willingness and ability to sign a written informed consent.
Exclusion Criteria:
* Prior radiation to the largest lesion in the lung.
* Current pregnancy or breast-feeding.
* Unwillingness or inability to practice contraception.
* Renal insufficiency.
* Comorbidities of grade 3 or greater.
* Concurrent medical or psychiatric conditions as defined by the treating physician which would preclude safe performance of study procedures or compromise the ability of the patient to consent to study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01114958
Study Brief:
Protocol Section:
NCT01114958